- 2022 - present
Steering Committee MemberAstraZeneca ENHERTU
- 2022 - present
MemberMayo Clinic Institutional Review Board (IRB)
- 2022 - present
Podcast HostAcademic and Community Clinical Research United (ACCRU)
- 2022 - present
Steering Committee MemberHER2CLIMB-05 Clinical Trial (NCT05132582)
- 2021 - present
Study ChairA011801 (CompassHER2 RD), FDA Registration Trial
- 2021 - present
Principal InvestigatorTAEK-VAC-HerBy-001: TAEK-VAC-HerBy Vaccine in Advanced HER2+ Tumors
- 2021 - present
MemberNCI Breast Cancer Steering Committee, neoSTEEP Working Group
- 2020 - 2022
Principal InvestigatorT-DM1 With or Without Abemaciclib for the Treatment of HER2-Positive Metastatic Breast Cancer Trial
- 2020 - present
InterviewerMayo Clinic Breast Oncology Surgical Fellowship
- 2020 - present
Alliance Study ChampionEA1181, (CompassHER2-pCR): Preoperative THP and Postoperative HP in Patients Who Achieve a Pathologic Complete Response
- 2020 - present
Steering Committee MemberSGNTUC-028: A Randomized, Double-blind, Phase 3 Study of Tucatinib or Placebo in Combination with Trastuzumab and Pertuzumab as Maintenance Therapy for Metastatic HER2+ Breast Cancer (HER2CLIMB-05)
- 2020 - present
Principal InvestigatorSMX20-001: An Open-label, Multicenter Study Evaluating the Safety of Lasofoxifene in Combination with Abemaciclib for the Treatment of Pre- and Postmenopausal Women with Locally Advanced or Metastatic ER+/HER2- Breast Cancer and Have an ESR1 Mutation
- 2019 - present
Principal InvestigatorTBCRC 022: A Phase II Trial of HKI-272 (Neratinib), Neratinib and Capecitabine, and Neratinib and Ado-Trastuzumab Emtansine (T-DM1) for Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer and Brain Metastases
- 2019 - present
ASCO Trainee and Early Career Council, Career Conversations, MentorAmerican Society for Clinical Oncology
- 2017 - present
MemberMayo Clinic Women's Cancer Program
- 2017 - present
Breast Committee MemberAlliance for Clinical Trials in Oncology
- 2017 - 2021
Principal InvestigatorECTx: Minnelide 101 (MCR)- A Phase I, Multi-center, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide(TM) Capsules given alone or in combination with Protein-Bound Paclitaxel
- 2017 - present
MemberMayo Clinic Comprehensive Cancer Center, Women's Cancer Program
- 2017 - present
Co-Principal InvestigatorPROMISE Trial
- 2017 - present
Principal InvestigatorA Phase I Study of a Combination of MM-398 and Veliparib in Solid Tumors
- 2017 - present
Principal InvestigatorNRG-BR004, A Randomized, Double-Blind, Phase III Trial of Taxane/Trastuzumab/Pertuzumab with Atezolizumab or Placebo in First-Line HER2-Positive Metastatic Breast Cancer
- 2016 - present
MemberIrish Society of Medical Oncology
- 2016 - present
MemberAmerican Association for Cancer Research
- 2016 - 2021
Principal InvestigatorA Multicenter, Open-label, Phase II Study of Imprime PGG and Pembro in Subjects with Adv Melanoma Failing Treatment with CPI or TNBC Failing Front-line Chemo for Metastatic Disease / BT-CL-PGG-MEL/BCA-1621/MK3475 PN-545
- 2016 - present
Principal InvestigatorA Phase II Open-label, Randomized Study of PARP Inhibition (Olaparib), Either Alone or in Combination with Anti-PDL1 Therapy (Atezolizumab; MPDL3280A) in Homologous DNA Repair (HDR) Deficient Triple Negative Breast Cancer (TNBC)
- 2016 - present
Principal InvestigatorI3Y-MC-JPBZ monarcHER: A Phase II, Randomized, Multicenter, 3-Arm, Open-label Study to Compare the Efficacy of Abemaciclib Plus Trastuzumab with or without Fulvestrant to Standard-of-Care Chemotherapy of Physician's Choice Plus Trastuzumab
- 2016 - present
Principal InvestigatorS1416, Phase II Randomized Placebo-controlled Trial of Cisplatin with or without ABT-888 (Velparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer, with or without Brain Metastases
- 2014 - 2016
Medical Oncology Quality Assurance Committee memberNational Institutes of Health
- 2014 - present
CCR-FYI Steering CommitteeNational Institutes of Health
- 2013 - 2016
MemberThe Wild Geese Network of Irish Scientists in North America
- 2013 - present
ClinFelcom, NCI Clinical Fellows CommitteeNational Institutes of Health
- 2010 - present
MemberEuropean Society of Medical Oncology
- 2010 - present
MemberAlliance for Clinical Trials in Oncology
- 2010 - present
MemberAmerican Society for Clinical Oncology
- 2009 - 2012
MemberIrish Society of Medical Oncology